The market witnessed a substantial uptick in revenue from 2020 through 2025, growing from 4250 million in 2020 to 6480 million in 2025, with projections set to surpass 13,500 million by 2035. Year-on-year growth is propelled by increased procedure volumes, rapid device innovation, and the enhanced reimbursement environment. The outlook remains robust, as continued product launches and expansion into ambulatory care settings are further expected to drive market size through the forecast period.
Read More - https://bussinessinsights.com/research-report/north-america-interventional-radiology-products-market
Cardiology remains the top application segment for interventional radiology products in North America in 2025, representing nearly a third of total usage. Oncology is rapidly gaining ground, fueled by increasing minimally invasive tumor ablation and biopsy procedures. Significant growth is also observed in urology & nephrology and neurology owing to new device launches targeting complex interventions. The convergence of technological improvements and multi-disciplinary collaboration is broadening the scope of interventional radiology across specialties.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-interventional-radiology-products-market
Who are the key players in North America Interventional Radiology Products Market industry?
The top 5 players are Boston Scientific Corporation, Medtronic plc, GE Healthcare, Siemens Healthineers, and Philips Healthcare. These companies dominate the market through innovative product offerings, extensive distribution networks, strong R&D, and a consistent focus on advanced minimally invasive technologies to address the growing demand for interventional radiology solutions.
What is the North America Interventional Radiology Products Market growth?
The North America Interventional Radiology Products Market is experiencing robust growth, driven by technological advancements and increased adoption of minimally invasive procedures. For instance, Boston Scientific’s introduction of new image-guided therapy systems in 2023 has contributed to improved procedural outcomes, further propelling market expansion.
Which segment accounted for the largest North America Interventional Radiology Products Market share?
The angioplasty segment accounted for the largest market share due to widespread adoption in treating cardiovascular diseases. Minimally invasive angioplasty procedures are increasingly favored for their safety, effectiveness, and quicker patient recovery, making them the top application in the interventional radiology products market.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com